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The V-ATPases are a family of ATP-dependent proton pumps, involved in a variety of cellular processes, including bone breakdown. V-ATPase
enzymes that are too active in the latter process can result in osteoporosis, and inhibitors of the enzyme could be used to treat this disease. As a
first step in studying the structure and function of the membrane-embedded interface at which proton translocation takes place, and its role in V-
ATPase inhibition, synthetic peptides P1 and P2 consisting of 25 amino acid residues are presented here that mimic Vph1p helix 7 of yeast V-
ATPase. A single mutation R10A between peptide P1 and P2 makes it possible to focus on the role of the essential arginine residue R735 in proton
translocation. In the present work, we use a novel combination of spectroscopic techniques, such as CD spectroscopy, tryptophan emission spectra,
acrylamide quenching and parallax analysis, and polarity mismatch modeling to characterize the peptides P1 and P2 in lipid bilayer systems.
Based on both the spectroscopic experiments and the polarity mismatch modeling, P1 and P2 adopt a similar transmembrane conformation, with a
mainly a-helical structure in the central part, placing the tryptophan residue at position 12 at a location 4T2 A˚ from the centre of the lipid bilayer.
Furthermore, the arginine at position 10 in P1 does not have an effect on the bilayer topology of the peptide, showing that the long, flexible side
chain of this residue is able to snorkel towards the lipid headgroup region. This large flexibility of R735 might be important for its function in
proton translocation in the V-ATPase enzyme.
D 2005 Elsevier B.V. All rights reserved.Keywords: V-ATPase; Transmembrane peptide; Protein– lipid interaction; Arginine snorkeling; Tryptophan location; Polarity mismatch simulation1. Introduction
The vacuolar H+-ATPases, or V-ATPases, are a family of
proton pumps, which hydrolyze ATP and use the released
energy to pump protons across a membrane [1–3]. In most
cases this membrane surrounds an organelle in the cell, such as
a vacuole, endosome, or lysosome. The V-ATPase acidifies
these compartments, which is important for a variety of cellular0005-2736/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2005.08.010
Abbreviations: 5-DOX-PC, 1-Palmitoyl-2-stearoyl(5-DOXYL)-sn-glycero-
3-phosphocholine; 12-DOX-PC, 1-Palmitoyl-2-stearoyl(12-DOXYL)-sn-gly-
cero-3-phosphocholine; CD, Circular dichroism; DOPC, 1,2-Dioleoyl-sn-
glycero-3-phosphocholine; DOPG, 1,2-Dioleoyl-sn-glycero-3-[phospho-rac-
(1-glycerol)]; KSV, Stern–Volmer constant; L/P, Lipid to peptide molar ratio;
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E-mail address: marcus.hemminga@wur.nl (M.A. Hemminga).processes, including ligand–receptor dissociation, targeting of
enzymes and transport of small molecules. In certain cases, V-
ATPases can also be found in the cell membrane, where they
function in acidification of the extracellular space. This is for
example the case in osteoclasts, cells that break down bone
tissue by acidifying a small volume next to the bone [4]. When
the V-ATPase enzymes in osteoclasts are too active, bone
breakdown can exceed bone formation by osteoblasts, and a
disease known as osteoporosis develops. Selective and potent
inhibitors of the V-ATPase could be used to treat this disease;
this is one of the reasons why studying the structure, function,
and inhibitor binding sites of the V-ATPase is important [5].
The V-ATPases structurally resemble the F-ATPases, which
catalyze the opposite reaction: synthesis of ATP using the
energy from a proton gradient. The F-ATPases have been
studied extensively, and the resemblance has been useful in
building a structural and functional model of the V-ATPase
[1–3]. Recently, the structure at 2.1 A˚ resolution of the
membrane rotor ring from the vacuolar-type (V-type) sodium1716 (2005) 137 – 145
http://www
Fig. 1. Primary sequence of transmembrane helix 7 (TM7) of subunit a (Vph1p
of yeast V-ATPase [40], and the chemically synthesized peptides, P1 and P2
used in this work. In TM7, the chemically synthesized region is underlined. P1
contains 21 amino acid residues of TM7, with two lysines added on the C and
N-terminal ends of the peptide to facilitate reconstitution into bilayers. P2 has
the same sequence as P1, except for the mutation R10A. The amino acid
residues involved in this mutation are underlined and indicated in bold.
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Enterococcus hirae was obtained [6]. The subunits in this
ring are homologs of the 16-kDa and 8-kDa proteolipids found
in other V-ATPases and in F-ATPases, respectively. The V-
ATPase enzyme of yeast consists of two domains: the cyto-
plasmic, water-soluble V1 domain, at which ATP-hydrolysis
takes place, and the membrane-bound V0 domain. The latter
domain comprises a core formed by a hexameric complex of
the three different proteolipid subunits Vma3p (4), Vma11p
(1), and Vma16p (1), which is in contact with a
transmembrane element of Vph1p. Interaction between a
glutamate (E137) in the putative transmembrane helix 4 of
the proteolipid subunits and an arginine (R735) in the putative
transmembrane helix 7 of Vph1p are found to be essential for
proton translocation [7].
The V-ATPases are thought to operate via a mechanism, in
which rotation of the hexameric ring of Vma3p, Vma11p, and
Vma16p relative to Vph1p drives unidirectional proton transport
[3]. Vph1p [8] and Vma3p [9–12] in V-ATPase, as well as the
interface between the corresponding subunits in the related F-
ATPase [13] are shown to bind bafilomycin and concanamycin,
which are well-known inhibitors of these enzymes.
Synthetic peptides that resemble trans-membrane sections of
membrane proteins are suitable model systems for biophysical
studies to obtain insight in the molecular interactions that play
a role in the native system [14–18]. This approach is justified
by the two-stage model of membrane protein folding, which
suggests that trans-membrane helices are independently stable
in lipid bilayers. Studying a single helix may thus provide
insight into the more complex membrane protein [19–21].
The amino acid sequence of the peptides, hydrophobic
matching, and interfacial anchoring determine the interactions
of the peptides with the lipid bilayer, and with other membrane-
inserted peptides, and hence their bilayer topology [22–27].
Although hydrophobic residues tend to predominate in
transmembrane helices, polar and ionisable residues are
particularly important in determining helix behavior. The
ability of such residues to form hydrogen bonds or salt bridges
often promotes helix–helix interactions [28–33], similar as
would be expected for those between Vph1p helix 7 and
Vma3p helix 4. Single transmembrane helices can also contain
polar or ionisable residues, although the introduction of too
many hydrophilic residues can result in the formation of shifted
or non-transmembrane states [34,35]. Residues having a longer
side chain, such as lysines or arginines, can be buried in the
bilayer core more easily because they can position their
charged group near the lipid headgroups by snorkeling towards
the lipid/water interface [15,35–38].
As a first step in studying the structure and function of the
membrane-embedded interface between helix 4 of Vma3p and
helix 7 of Vph1p, and its role in V-ATPase inhibition, synthetic
peptides are presented here that mimic Vph1p helix 7 of yeast V-
ATPase [3,7] (see Fig. 1). The designed peptides contain a single
Trp residue near the centre of the peptide sequence that enables
the study of their physicochemical behavior in lipid bilayer
systems by fluorescence spectroscopy. A single mutation R10A
between peptide P1 and P2 makes it possible to focus on the role)
,of R735 in the complex formation and proton translocation of the
V-ATPase. Both peptides have two lysines added on the C and
N-terminal ends that serve as membrane anchors and improve
the solubility of the peptides [24,39].
In the present work, we use a novel combination of
spectroscopic techniques and polarity mismatch modeling to
characterize the peptides P1 and P2 in lipid bilayer systems.
Comparison of the behavior of P1 and P2 allows us to
specifically study the role of the arginine residue R735 in the
determination of the bilayer topology of the peptides, and to
extend this to its role in the native system.
2. Materials and methods
2.1. Chemicals
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC; (18:1)2-PC) was pur-
chased from Sigma and 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]
(DOPG; (18:1)2-PG) was purchased from Avanti Polar Lipids Inc. Spin-labeled
lipids 1,2-dioleoyl-sn-glycero-3-phospho(TEMPO)choline (TEMPO-PC),
1-palmitoyl-2-stearoyl-(5-DOXYL)-sn-glycero-3-phosphocholine (5-DOX-PC)
and 1-palmitoyl-2-stearoyl-(12-DOXYL)-sn-glycero-3-phosphocholine (12-
DOX-PC) were purchased from Avanti Polar Lipids Inc. All other chemicals and
solvents were purchased from Merck, except for TFE, which was from Acros
organics.
2.2. Peptide synthesis and design
The peptides P1 and P2 (see Fig. 1) were produced on solid support using
continuous flow chemistry by Pepceuticals Ltd., Leicester, UK and used
without further purification. The final purity was tested by HPLC and mass
spectrometry, and was above 90% in all cases. Peptide P1 contains 21 residues
from the native sequence [40] of trans-membrane helix 7 of yeast V-ATPase
Vph1p, which has recently been established to run from residues V727 to
T752 [2,3,7]. Arginine R735 in the native sequence [40] corresponds to R10
in the peptide. This arginine has shown to be essential for proton translocation
of the V-ATPase [7].
On both sides of the peptide, two lysines are added. This approach is
frequently used in studies of membrane-bound peptides, as lysines are known
to increase solubility, stabilize membrane insertion by interaction with anionic
lipid headgroups, promote a trans-membrane configuration and minimize
aggregation [24,27,41]. The arginine residue in peptide P1 is the only residue
that is essential for proton transport activity in the native enzyme. To study its
role in more detail, a second peptide (P2) is designed, with the single
substitution R10A. In both peptides, the centrally located tryptophan residue
W12 acts as a fluorescence reporter group.
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peptides. It may be that in the V-ATPase complex helix 7 is not exposed to
lipids, however, phospholipid bilayers provide the best possible polarity
gradient from an apolar to a polar medium to incorporate this protein domain
for our biophysical work [24,27,41].
2.3. Vesicle preparation
Desired amounts of lipids (DOPC and DOPG in 4:1 mole ratio, further
denoted as DOPC/DOPG) in chloroform and peptides in methanol (P1) or TFE
(P2), were mixed and dried under a stream of nitrogen. Traces of solvent were
removed by further evaporation over night under vacuum. Buffer (10 mM
NaH2PO4/Na2HPO4, pH=7.0) was added to the dried samples, and three
cycles of vortexing, freezing, and thawing were carried out to obtain crude
multilamellar vesicles. The large unilamellar vesicles (LUVs) used in this
study were prepared by extrusion, using filters with 100 nm pore size.
Although small unilamellar vesicles (SUVs) would have a lower light
scattering having less interference with our optical experiments, they are
known to produce anomalous peptide binding, resulting perhaps from distorted
lipid packing associated with the high surface curvature. On the contrary,
LUVs have larger radii of curvature and are therefore more suitable models of
biological membranes; for that reason, LUVs are used in the present work
[42].
2.4. CD measurements
CD spectra were recorded using a Jasco spectropolarimeter J-715. The
samples contained 1 mM of lipid and 18 AM of peptide (L/P=55) and were
measured in a cuvette with 1 mm pathlength. Spectra were recorded between
190 and 260 nm using the following parameters: scan speed 50 nm min1, data
pitch 0.5 nm, 2 s response time, 1 nm bandwidth. Forty spectra were
accumulated and the background signal was subtracted. The spectra were
analyzed using the freeware program CDNN 2.1 [43].
2.5. Absorption and fluorescence measurements
Absorption measurements were carried out on a Cary 5E (Varian)
spectrophotometer. Absorption spectra were recorded to determine peptide
concentrations, using the well-known extinction coefficients of tryptophan and
tyrosine [44], and to correct for inner filter effects in our fluorescence
experiments. Fluorescence spectra were recorded on a Fluorolog 3.22 (Jobin
Yvon-Spex), using 1 ml quartz cuvettes with pathlengths of 10 and 4 mm in the
excitation and emission direction, respectively. Fluorescence spectra were
recorded between 300 and 500 nm, using an excitation wavelength of 290 nm
and using excitation and emission slits giving a 2-nm bandpass. Spectra were
corrected for wavelength dependent variations in the detection, and for
background fluorescence. To correct for the inner filter effect Eq. (1) was
used [45]:
Fcorr ¼ Fobs10 lexAexþlemAemð Þ=2: ð1Þ
Here, Fobs and Fcorr are the observed and the corrected fluorescence
intensities, respectively. Aex and Aem are the absorbances at the excitation and
emission wavelengths, respectively. lex and lem are the lengths in cm of the
optical paths of excitation and emission, respectively. For the fluorescence
measurements, the lipid concentration was 200 AM and the peptide
concentration 2 AM (L/P=100). In all cases, the background signal was at
most 10% of the total signal.
2.6. Quenching experiments
For acrylamide quenching experiments, 5 Al aliquots of a 3 M stock
solution were added to 1 ml samples, until a final concentration of 0.12 M
acrylamide was reached. The fluorescence intensity was measured after each
addition. Measurements were repeated until there was no decrease in intensity
to any further extent. The fluorescence intensity was corrected for the dilution
by the acrylamide solution. Quenching of a homogeneous population offluorophores, either via a collisional or via a static process, follows the Stern–
Volmer equation [45]:
F0
F
¼ 1þ KSV Q½ : ð2Þ
In this equation, F0 and F are the fluorescence intensities in the absence and
presence of quencher, respectively. [Q] is the quencher concentration and KSV
the Stern–Volmer constant. KSV provides information on the accessibility of
the fluorophores to the quencher [45].
2.7. Parallax analysis
In a so-called parallax analysis the extent of quenching by lipids labeled
with a doxyl group at different depths is compared, and the distance of the
tryptophan residue to the centre of the bilayer is calculated from these
quenching efficiencies [46]. In this study, the amount of quenching by PC
lipids with a spin-label linked to the headgroup or to the hydrocarbon chain
at C-atom number 5 or 12 (TEMPO-PC, 5-DOX-PC, and 12-DOX-PC,
respectively) is compared. For this purpose 12.5 mol% of DOPC was
replaced by spin-labeled lipid. This gives a final concentration of 10 mol%
spin-labeled lipid in the samples. The decrease in fluorescence intensity in
the samples with TEMPO, 5-DOX, or 12-DOX-PC compared to the sample
without spin-labeled lipid gives an indication of the position of the
tryptophan residue. Only the data from the latter two were used to calculate
the depth of the tryptophan residue in the bilayer.
The decrease in fluorescence intensity in the samples with 5 or 12-DOX-PC
compared to the sample without spin-labeled lipid was used to calculate the
depth of the tryptophan residue in the bilayer. For the calculation of the Trp to
bilayer centre distance (zcf), taking into account quenching by the deep
quencher from both leaflets of the lipid bilayer, the following modified version
of the parallax equation was used [23]:
zcf ¼ Lc2  1pC ln
F1
F0
 2,
F2
F0
)(
2L221þ4L2c2
! ,
4 L21þLc2ð Þ
#"
ð3Þ
In this equation Lc2 is the difference in depth between the deep quencher
(12-DOX-PC) and the bilayer centre, L21 is the difference in depth between the
shallow (5-DOX-PC) and the deep (12-DOX-PC) quencher and C is the
concentration of the quencher in molecules per A˚2. F0, F1, and F2 are the
fluorescence intensities in the absence of quencher, and in the presence of
5-DOX-PC and 12-DOX-PC, respectively.
2.8. ESR measurements
Samples containing spin-labeled lipid were checked by ESR measure-
ments to ensure that all samples contained equal amounts of unpaired
electrons (quenchers). First derivative absorption ESR spectra were measured
at room temperature on an X-band Bruker ESP 300 E spectrometer. The
sweep width of the recorded spectra was 20 mT, the microwave power was
10 mW, the field frequency was 9.33 GHz, and the centre of the field was
0.333 T. The samples were contained in 200 Al capillaries. Only small
differences were found between the samples, for which corrections were made
in the calculations.
3. Results
3.1. CD spectroscopy
In Fig. 2, the CD spectra of P2 in buffer and reconstituted
into DOPC/DOPG vesicles are presented. The result for P1 is
identical (data not shown). The spectrum of the peptide in
buffer indicates a predominantly unordered conformation with
low helix content. The spectrum of the reconstituted peptide on
the other hand, has a higher intensity and shows minima at 208
and 222 nm, characteristic for an a-helix conformation.
Fig. 2. CD spectra of P2 in buffer (dashed line) and reconstituted into DOPC/
DOPG vesicles (solid line). In buffer the peptide is predominantly unstructured
with an a-helical content of 1¨5%, while in vesicles the peptide has more
structure with a helicity of ¨45%.
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bound conformation is confirmed by quantitative analysis
using the program CDNN 2.1. In buffer, the peptide has a helix
content of 15T5%, the remainder being mainly random coil
(40%). For the vesicle-bound form, the helix content is
45T5%, while the percentage random coil has decreased to
about 25–30%. The error values are due to uncertainties in
peptide concentration.
3.2. Fluorescence spectra
The fluorescence spectra of P1 and P2 in buffer (see Fig. 3)
resemble that of the earlier reported class III tryptophan
fluorescence spectrum [47] and nearly coincide with that of
free tryptophan in water. This indicates that at low peptide
concentrations the peptides are soluble in water and do not tend
to aggregate; aggregation would place the tryptophan residue inFig. 3. Normalized fluorescence spectra of P1 (dashed line) and P2 (solid line)
in buffer (thin lines) and reconstituted into DOPC/DOPG vesicles (thick lines).a more hydrophobic peptide environment, and thereby shift the
fluorescence maximum to the blue. Fig. 3 also shows the
fluorescence spectra of P1 and P2 reconstituted into DOPC/
DOPG vesicles. The fluorescence maxima of P1 and P2 in
vesicles are 330 and 329 nm, respectively, giving a blue shift of
approximately 20 nm as compared to the maxima found for the
peptides in buffer. In our studies with varying L/P ratio, the
fluorescence spectra were already completely blue-shifted at
the lowest lipid concentration, and did not shift anymore at
higher lipid concentrations. This is a strong indication for
complete membrane association of the peptides at all L/P
ratios.
3.3. Acrylamide quenching
In Fig. 4, the Stern–Volmer plot for acrylamide quenching
of P1 and P2 reconstituted in DOPC/DOPG vesicles is shown.
For comparison Stern–Volmer plots for completely accessible
free tryptophan in water [45] and for tryptophan completely
buried in a membrane [14,22,48] are included.
3.4. Parallax analysis
In Fig. 5a, fluorescence spectra are presented for P2 in
DOPC/DOPG vesicles in the absence and presence of spin-
labeled lipids. The spectra show a decreasing quenching
efficiency in the order: 12-DOX-PC>5-DOX-PC>TEMPO-
PC. To observe possible quencher-induced shifts, the normal-
ized fluorescence spectra for P2 in vesicles in the absence and
presence of either 5-DOX-PC or 12-DOX-PC are presented in
Fig. 5b. The results for P1 are similar (not shown here). In this
figure, it can be seen that although the line shapes show a smallFig. 4. Stern–Volmer plots for acrylamide quenching of P1 (r) and P2 (>) in
vesicles with their fits (thick and thin solid line, respectively) according to Eq
(2). Theoretical lines for completely shielded (dotted line; KSV=1.2 M
1
[14,22,48]) and completely exposed tryptophan (dashed line; KSV=16 M
1
[45]) are included for comparison..
Fig. 5. (a) Fluorescence spectra of P2 in DOPC/DOPG vesicles containing
10% TEMPO-PC (thin solid line), 5-DOX-PC (dotted line), or 12-DOX-PC
(dashed line), having intensities normalized to that without quencher (thick
solid line); (b) Normalized fluorescence spectra of P2 in DOPC/DOPG
vesicles, showing small shifts of the fluorescence maximum upon addition of
5-DOX-PC (dotted line), and 12-DOX-PC (dashed line), with respect that with
no quencher (solid line).
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hardly change.
4. Discussion
In this study, we have presented model peptides (P1 and P2)
for helix 7 of Vph1p of the V-ATPase enzyme. Peptide P1
contains a specific arginine R735 from the V-ATPase, which is
essential for proton translocation by this enzyme. In peptide P2,
the arginine is mutated into an alanine to enable to examine the
role of the arginine in the enzyme. By using CD spectroscopy
and different fluorescence techniques, including tryptophan
emission spectra, quenching by acrylamide and parallax
analysis, the behavior of the peptides in phospholipid vesicles
is characterized.
4.1. CD spectra
Qualitative as well as quantitative analysis of the CD spectra
shown in Fig. 2 demonstrate that both peptides P1 and P2 are
mainly unstructured in buffer, while they adopt a ¨45%
a-helical conformation in vesicles. The shape of the CDspectrum in vesicles is very similar to the shape of a perfect
a-helix, however, the intensity is reduced. We interpret this
observation as arising from motional dynamics of the peptide
backbone. The small a-helical peptides P1 and P2 are expected
to be relatively flexible systems undergoing rapid equilibria
among multiple conformational states. This means that longer
helices would break up in smaller domains in a dynamic way.
From theoretical CD studies it is known that a-helices with a
smaller length give rise to a lower CD intensity [49]. Most
probably, the C and N-terminal ends of the peptide sequence,
consisting of positively charged lysines and some other polar
residues, form a non-helical structure to interact as favorably as
possible with the negatively charged phospholipid headgroups.
Therefore, it follows that the more hydrophobic core of the
peptides, including the arginine at position 10 for peptide P1,
most likely forms an a-helical structure.
4.2. Fluorescence spectra
The maxima of the tryptophan fluorescence of P1 and P2 in
DOPC/DOPG vesicles (¨330 nm, see Fig. 3) fall well within
the range of values (315 to 344 nm) found for tryptophan
residues in the apolar centre of a membrane [14,22–25,48]. As
compared to the lowest reported values, the fluorescence
maximum is somewhat red shifted, suggesting a position of the
tryptophan residue slightly off the centre of the membrane.
However, in the case of an a-helical peptide conformation, the
red shift could also result from tryptophan forming a hydrogen
bond with the tyrosine [47], which is located at the fourth
position from the tryptophan.
It is striking to note that there is a strong resemblance between
the fluorescence properties of P1 and P2 after reconstitution.
This suggests a minor contribution of the strongly hydrophilic
arginine at position 10 to the bilayer topology of peptide P1, in
agreement with the CD results.
4.3. Acrylamide quenching
From the Stern–Volmer plots presented in Fig. 4, the Stern–
Volmer constants (KSV) were calculated for P1 and P2 in
vesicles according to Eq. (2). For both peptides the KSV values
amount to a value of 4.4T0.4 M1. This value is in between the
KSV for completely water-accessible (KSV=16 M
1) [45] and
completely shielded (KSV=1.2 M
1) tryptophan [14,22,48],
indicating that for both peptides the tryptophan residue is
buried to some extent into the membrane, being still slightly
accessible to acrylamide. The Stern–Volmer plots do not show
a deviation from linearity. This is indicative for a high
population homogeneity [45] and suggests the existence of
only a transmembrane population of the peptides in DOPC/
DOPG vesicles, consequently having their tryptophan residues
close to the centre of the membrane. The observed blue shift of
the fluorescence maximum of the peptides in vesicles as
compared to that in buffer is in agreement with this finding.
Furthermore, a transmembrane configuration is supported by
fluorescent studies of a peptide similar to P1 in which the
arginine at position 10 is replaced by a histidine that has been
Fig. 6. Model describing the peptide incorporation into the bilayer given by the
spatial parameters d, h, and x. The center of mass of each amino acid residue
was calculated taking into account the coordinates and atomic weights of al
peptide atoms. The normal to the membrane plane is shown by the z-axis with
z =0 corresponding to the membrane center, the symmetry axis of the peptide
by the axis O.
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(Hesselink et al., unpublished results).
4.4. Parallax analysis
The fluorescence maxima and acrylamide quenching results
only give a first indication of the position of the tryptophan in
the centre of the membrane, but not a quantitative value.
However, the parallax method allows us to calculate the depth
of the tryptophan residue more accurately, leading to a more
precise model for the membrane topology of the peptides.
Qualitatively, the decreasing order in quenching efficiency 12-
DOX-PC>5-DOX-PC>TEMPO-PC (see Fig. 5a) confirms the
location of the tryptophan residue close to the centre of the
bilayer. Quantification of the data using Eq. (3), results in
distances of the tryptophan residue to the centre of the bilayer
of 4.7 and 4.0T1.9 A˚ for P1 and P2, respectively. The error
value arises from the calculated standard deviations from
measurements of four independent reconstitutions. The large
error value is due to the uncertainty in peptide concentration,
which was determined to be approximately 10%.
Quencher-induced shifts of the fluorescence spectrum can
reveal possible heterogeneity of the peptide population. In a
sample containing a heterogeneous peptide population, with
both deep and shallow tryptophan residues, 5-DOX-PC would
quench the latter most strongly, inducing a blue shift, while 12-
DOX-PC would have the opposite effect. However, in a
homogeneous peptide population no large differences between
kmax with and without quenchers would be observed, although
even for a relatively uniform peptide population small
quencher-induced shifts could be expected due to the distribu-
tion of peptides around an average depth.
For P1 and P2 quencher-induced shifts of the flanks of the
line shape in the expected directions are indeed observed (see
Fig. 5b), but these shifts are small (1 to 2 nm) and kmax is
practically the same for all spectra. This strongly indicates a
homogeneous conformation and bilayer topology of both
peptides P1 and P2 [48].
4.5. Simulation of polarity mismatch between peptides and
lipid bilayer
Based on the spectroscopic experiments, P1 and P2 appear
to adopt a similar a-helical conformation in lipid bilayers, in
which the tryptophan residue is placed near the centre of the
bilayer. Furthermore, the arginine at position 10 in P1 does not
have an effect on the bilayer topology of the peptide. To
support the conclusions from our experiments, we have carried
out calculations to minimize the polarity mismatch between the
peptide and membrane, allowing for all possible orientations
and locations of the peptide with respect to the bilayer.
Although CD analysis shows that the conformation of the
peptides is different in the water phase as compared to the lipid
phase, and that the a-helical content in the lipid phase may not
be 100% due to motional dynamics, for simplicity, we will
assume in our calculations a full a-helix for the peptides under
all conditions.For the mismatch calculations, three spatial parameters were
introduced, defining the position and orientation of the peptide
in the bilayer. The related parameters are given by the distance
d between the centre of mass of the peptide and the membrane
centre, the peptide tilt angle h, i.e., the angle between the
peptide helix and the normal to the membrane surface, and the
angle of the coaxial rotation of the peptide x (Fig. 6). In the
simulation model, the charge density profile of the bilayer and
the polarity scales of the amino acid residues were used [50].
To make the scales applicable for polarity mismatch optimi-
zation, their values were normalized to the range 0 to 1, with 0
corresponding to the most hydrophobic amino acid residue.
The polarity profile of the bilayer [50] was approximated by
the following empirical equation:
P zð Þ ¼ 1
1þ zC=zð Þ8
: ð4Þ
In this equation P(z) is the scaled polarity at distance z from
the bilayer centre and zC is half the thickness of the hydro-
phobic membrane region (see Fig. 7a).
The hydrophobicity scales for the amino acid residues [50]
include the free energies of amino acid residues transfer from
water to the bilayer interface and from water to n-octanol. The
mean value of the two free energies, scaled to the range [0,1],
was taken as the scaled polarity p of an amino acid residue (see
Fig. 7b). The total polarity mismatch M for a peptide,
consisting of N amino acid residues, is then calculated as
follows:
M ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
~
N
i¼l
P zið Þ  pið Þ2
s
: ð5Þ
Here, zi is the distance of the centre of mass of the ith amino
acid residue to the bilayer centre and pi is the polarity of thisl
Fig. 7. (a) Scaled polarity profile approximation of a bilayer [50]. The thickness of a single lipid leaflet of the hydrophobic membrane region is given by zC. (b) Scaled
polarity values for different amino acid residues originating from White and Wimley’s scale [50].
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the orientation (h, x) and depth d of the peptide with respect to
the membrane. Therefore, the Nelder–Mead optimization
algorithm [51] was applied to find the parameters d, h, and
x corresponding to the state of the peptide with the smallest
mismatch. This algorithm provides a reasonable convergence
and is not extremely time consuming. It should be noted that
we use here a simplified model that is only based on
hydrophobic effects. For example, we do not take into account
electrostatic effects of the phospholipid headgroups. However,
the presence of negatively charged lipid headgroups of DOPG
will increase the anchoring of the positively charged lysines
and therefore stimulate a transmembrane orientation of the
peptides.
Minimizations of the polarity mismatch between the
peptides and the membrane were performed 1000 times with
different initial estimations of d, h, and x to avoid trapping
in local minima. The resulting global minimum for the
mismatch corresponds to the transmembrane orientations for
both P1 and P2, almost perpendicular to the plane of the
bilayer (see Fig. 6) with tilt angles h equal to 5 and 2-,
respectively. The peptide depth d was 1.1 and 1.2 A˚,
respectively. In this situation, the tryptophan residues of P1
and P2 are located at 2.3 and 2.6 A˚ from the membrane
centre, respectively. These values are close to the distances
calculated from the parallax analysis. The small difference
between the parallax and simulated position can be the result
of partial unwinding of the a-helix at the peptide termini.
This unwinding can allow the protein to take an energetically
more appropriate position.
Hardly any difference is observed between P1 and P2, both
in the spectroscopic experiments and in the polarity mismatch
simulations. In the simulations, the mismatch for P1 is only 5%
higher than for P2, and the most probable state is the same
transmembrane configuration for both peptides. Clearly, the
polarity difference between arginine and alanine makes a small
difference in total mismatch for the 25 amino acid residue
peptides. For the CD spectra, the tryptophan emission spectra,
the acrylamide quenching experiment and the parallax analysis
the differences are also negligible. This indicates a minor effect
of the mutation R10A on the bilayer topology of the peptide,
probably because arginine is able to position its guanido groupin a more favorable position via snorkeling; this results in a
lower effective polarity.
4.6. Summarizing discussion
Based on our findings, the peptides P1 and P2 adopt a
transmembrane conformation, with a mainly a-helical structure
in the central part, placing the tryptophan residue at position 12
at a location 4T2 A˚ from the centre of the lipid bilayer. For
both peptides, the experimental results are in good agreement
with the results obtained from polarity mismatch optimization.
Consequently, the arginine at position 10 in peptide P1 is also
located in the hydrocarbon core of the bilayer.
The peptides P1 and P2 are not very hydrophobic: about
half of the residues are hydrophilic, the peptides contain several
positively charged residues, and they dissolve readily in water.
Nevertheless, the peptides appear to adopt a transmembrane
configuration when vesicles are present.
For peptide P2, this intriguing behavior can be easily
explained by looking carefully at the amino acid sequence. The
central part of P2 is mainly hydrophobic, uncharged at neutral
pH, and long enough to span a DOPC/DOPG bilayer. Favor-
able interactions of the flanking lysines with the negatively
charged DOPG headgroups [27,52], combined with these
hydrophobic interactions, promote the formation of a trans-
membrane helix.
Peptide P1, on the other hand, contains an arginine residue
in its hydrophobic core, which normally would be positively
charged at neutral pH, and its presence is expected to affect the
membrane topology of the peptide. Nonetheless, no significant
difference between P1 and P2 is observed. This raises ques-
tions about the behavior and protonation state of the arginine
residue in P1 in a phospholipid bilayer system.
The arginine residue of peptide P1 is located at position 10,
two residues further away from the centre of the bilayer as
compared to the tryptophan. This would place it at approxi-
mately 7 A˚ from the bilayer centre, assuming an a-helical
conformation. This location makes it possible for the arginine
side chain to snorkel, thereby positioning its positively charged
guanido group near the phospholipid headgroups. Both
arginines and lysines are able to span a distance of about 6
A˚ with their long side chains, and can therefore, despite their
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below the membrane/water interface [36]. Snorkeling effects
have been invoked before to explain the positioning of charged
residues in transmembrane helices in the hydrophobic core of
the bilayer [15,35–38].
The fact that hardly any difference is observed between the
behavior of the peptides P1 and P2 shows that the long,
flexible side chain of the arginine residue in P1 is able to
snorkel towards the lipid headgroup region, without altering
the membrane topology of the peptide. Clearly snorkeling of
the arginine is possible without causing any ‘‘stress’’ on the
peptide backbone and other side chains. Charged residues with
a shorter side chain, such as aspartic and glutamic acid, and
arginines and lysines placed deeper in the hydrocarbon core of
the bilayer, often promote the formation of shifted or tilted
transmembrane structures, or even a non-transmembrane
peptide population [15,35,36]. The arginine residue in P1 on
the other hand, has a side chain long enough to reach the lipid
headgroup region from its position five to six residues into the
hydrocarbon core.
Apart from the essential arginine R735, helix 7 of Vph1p
contains two histidine residues (H729 and H743), which
are important, although not essential, for V-ATPase activity
[53,54]. These histidines, located at position 4 and 18 in P1 and
P2, could probably also be located in the a-helix, shown from
our work to be formed in the more hydrophobic core of the
peptides. His18 would be positioned at about the same depth in
the lipid bilayer as the arginine, His4 is somewhat closer to the
membrane–water interface. The histidines are not charged at
neutral pH, but can easily pick up a proton at lower pH.
Compared to arginine, the side chains of the histidines are
relatively rigid [55]. The histidine residues are suggested to line
the access channels leading to the carboxyl groups in Vma3p,
Vma11p and Vma16p, probably via their ability to reversibly
pick up protons.
Peptide P1 contains the essential arginine R735, which is
proposed to interact with the glutamic acid residues in the
proteolipid subunits and to force the release of protons into the
luminal access channel, thereby directing unidirectional proton
transport [3]. The relatively high flexibility of the arginine side
chain as deduced from its snorkeling, might be a mechanism to
facilitate these interactions in the V-ATPase enzyme. During
proton transport, the favorable salt bridge between the posi-
tively charged arginine in Vph1p and the negatively charged
glutamic acid in Vma3p, Vma11p or Vma16p has to be broken
for the process to continue. The energy for breaking this bond
comes from ATP hydrolysis, which results in rotation of the
ring of proteolipid subunits. The fact that the long, flexible
arginine side chain is able to reach towards the next glutamic
acid residue directly after disturbance of interaction might
facilitate this process.
Inhibitors of the V-ATPase enzyme, such as bafilomycin and
concanamycin, are shown to bind to the V0 domain, most
probably to the interface between Vph1p and the ring of
proteolipid subunits [8–10]. Binding of these molecules to this
interface could reduce the flexibility of the essential arginine
R735, thereby interfering with its interactions with the glutamicacid residues. The peptides presented in this work are excellent
model systems to study these interactions of Vph1p, both with
the proteolipid subunits and with V-ATPase inhibitors (Hesse-
link, R.W., et al., unpublished results) in further detail.
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